Atypical multiple sclerosis associated with indolent systemic mastocytosis treated by cladribine

Rev Neurol (Paris). 2023 Oct;179(8):925-927. doi: 10.1016/j.neurol.2023.03.020. Epub 2023 Jul 26.
No abstract available

Publication types

  • Letter

MeSH terms

  • Cladribine / therapeutic use
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Mastocytosis, Systemic* / complications
  • Mastocytosis, Systemic* / diagnosis
  • Mastocytosis, Systemic* / drug therapy
  • Multiple Sclerosis* / complications

Substances

  • Cladribine
  • Immunosuppressive Agents